Did You Know?

Editor’s Picks

Latest News

Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC

SHANGHAI, July 21, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading...

Outsourcing Medical Billing to Capline Healthcare Management Saves Practices Up to 40% in Administrative Costs While Accelerating Reimbursements by 2X

As staffing shortages, rising operating costs, and increasing administrative workloads continue to challenge independent medical practices, Houston-based revenue cycle management...

error: Content is protected !!